Real-time enrollment status for this metastatic colorectal cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:46 AM UTC
| NCT Number | NCT04929223 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Colorectal Cancer |
| Phase | PHASE1 |
| Target Enrollment | 542 participants |
| Active Locations | 35 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | August 17, 2026 (1 week ago) |
As of August 27, 2026: Clinical trial NCT04929223 is currently recruiting participants. This phase1 study for metastatic colorectal cancer is actively seeking new participants at 35 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04929223 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04929223 was last updated 1 week ago (August 17, 2026). HelloStudys verifies this status automatically.